COP regimen

Jump to navigation Jump to search

WikiDoc Resources for COP regimen

Articles

Most recent articles on COP regimen

Most cited articles on COP regimen

Review articles on COP regimen

Articles on COP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on COP regimen

Images of COP regimen

Photos of COP regimen

Podcasts & MP3s on COP regimen

Videos on COP regimen

Evidence Based Medicine

Cochrane Collaboration on COP regimen

Bandolier on COP regimen

TRIP on COP regimen

Clinical Trials

Ongoing Trials on COP regimen at Clinical Trials.gov

Trial results on COP regimen

Clinical Trials on COP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on COP regimen

NICE Guidance on COP regimen

NHS PRODIGY Guidance

FDA on COP regimen

CDC on COP regimen

Books

Books on COP regimen

News

COP regimen in the news

Be alerted to news on COP regimen

News trends on COP regimen

Commentary

Blogs on COP regimen

Definitions

Definitions of COP regimen

Patient Resources / Community

Patient resources on COP regimen

Discussion groups on COP regimen

Patient Handouts on COP regimen

Directions to Hospitals Treating COP regimen

Risk calculators and risk factors for COP regimen

Healthcare Provider Resources

Symptoms of COP regimen

Causes & Risk Factors for COP regimen

Diagnostic studies for COP regimen

Treatment of COP regimen

Continuing Medical Education (CME)

CME Programs on COP regimen

International

COP regimen en Espanol

COP regimen en Francais

Business

COP regimen in the Marketplace

Patents on COP regimen

Experimental / Informatics

List of terms related to COP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: CVP; CVP regimen; Cyclophosphamide/Vincristine/Prednisone

Overview

COP regimen refers to a regimen consisting of cyclophosphamide, vincristine, and prednisone used to treat Non Hodgkin's lymphoma.

Regimen

CCyclophosphamide

OVincristine (Oncovin)

PPrednisone

Indications

References

  1. Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL; et al. (1971). "Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma". Cancer. 28 (2): 306–17. PMID 4935774.